Goldman Sachs’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$124M Buy
2,582,456
+604,853
+31% +$28.2M 0.01% 905
2025
Q4
$95.8M Sell
1,977,603
-501,725
-20% -$24.9M 0.01% 1017
2025
Q3
$117M Sell
2,479,328
-163,354
-6% -$7.88M 0.01% 843
2025
Q2
$128M Sell
2,642,682
-132,494
-5% -$6.77M 0.02% 752
2025
Q1
$154M Sell
2,775,176
-82,952
-3% -$4.49M 0.02% 605
2024
Q4
$138M Sell
2,858,128
-795,506
-22% -$40.4M 0.02% 650
2024
Q3
$211M Buy
3,653,634
+345,720
+10% +$18.7M 0.03% 499
2024
Q2
$160M Buy
3,307,914
+604,277
+22% +$29.1M 0.03% 579
2024
Q1
$131M Buy
2,703,637
+352,968
+15% +$17.2M 0.02% 645
2023
Q4
$117M Sell
2,350,669
-214,630
-8% -$10.5M 0.02% 705
2023
Q3
$138M Sell
2,565,299
-168,906
-6% -$9.01M 0.03% 572
2023
Q2
$147M Buy
2,734,205
+90,056
+3% +$4.85M 0.03% 552
2023
Q1
$144M Buy
2,644,149
+135,353
+5% +$6.58M 0.03% 541
2022
Q4
$122M Buy
2,508,796
+72,537
+3% +$3.18M 0.03% 626
2022
Q3
$92.6M Sell
2,436,259
-207,356
-8% -$9.24M 0.02% 727
2022
Q2
$132M Buy
2,643,615
+515,245
+24% +$27.3M 0.03% 552
2022
Q1
$109M Sell
2,128,370
-99,310
-4% -$5.13M 0.02% 717
2021
Q4
$112M Buy
2,227,680
+578,452
+35% +$28.6M 0.02% 740
2021
Q3
$79.5M Sell
1,649,228
-154,652
-9% -$7.86M 0.02% 899
2021
Q2
$95M Buy
1,803,880
+273,128
+18% +$14.3M 0.02% 764
2021
Q1
$75.7M Buy
1,530,752
+76,710
+5% +$3.69M 0.02% 838
2020
Q4
$70.7M Buy
1,454,042
+129,434
+10% +$6.38M 0.02% 852
2020
Q3
$66.5M Buy
1,324,608
+56,957
+4% +$2.93M 0.02% 802
2020
Q2
$64.7M Buy
1,267,651
+97,247
+8% +$4.73M 0.02% 777
2020
Q1
$51.2M Sell
1,170,404
-196,597
-14% -$9.41M 0.02% 845
2019
Q4
$68.6M Buy
1,367,001
+328,816
+32% +$15.4M 0.02% 937
2019
Q3
$48.1M Buy
1,038,185
+82,896
+9% +$3.58M 0.01% 1127
2019
Q2
$41.3M Sell
955,289
-9,794
-1% -$416K 0.01% 1280
2019
Q1
$42.7M Sell
965,083
-64,515
-6% -$2.76M 0.01% 1258
2018
Q4
$44.7M Sell
1,029,598
-16,622
-2% -$733K 0.01% 1174
2018
Q3
$46.7M Buy
1,046,220
+156,957
+18% +$6.7M 0.01% 1273
2018
Q2
$35.6M Buy
889,263
+153,779
+21% +$6.05M 0.01% 1479
2018
Q1
$29.5M Sell
735,484
-219,029
-23% -$9.11M 0.01% 1540
2017
Q4
$41M Sell
954,513
-51,387
-5% -$2.37M 0.01% 1431
2017
Q3
$50.1M Sell
1,005,900
-198,536
-16% -$9.61M 0.01% 1284
2017
Q2
$57.7M Buy
1,204,436
+60,410
+5% +$2.89M 0.01% 1141
2017
Q1
$51.8M Buy
1,144,026
+255,644
+29% +$10.8M 0.01% 1202
2016
Q4
$35.9M Sell
888,382
-360,418
-29% -$14.2M 0.01% 1509
2016
Q3
$47.7M Buy
1,248,800
+270,877
+28% +$10.9M 0.01% 1245
2016
Q2
$40.9M Buy
977,923
+24,156
+3% +$990K 0.01% 1262
2016
Q1
$38.3M Sell
953,767
-90,785
-9% -$3.65M 0.01% 1260
2015
Q4
$44.6M Buy
1,044,552
+122,328
+13% +$5.63M 0.01% 1214
2015
Q3
$43.8M Buy
922,224
+93,789
+11% +$4.78M 0.01% 1152
2015
Q2
$41M Buy
828,435
+25,226
+3% +$1.28M 0.01% 1250
2015
Q1
$39.7M Buy
803,209
+109,607
+16% +$5.24M 0.01% 1264
2014
Q4
$31.6M Buy
693,602
+15,592
+2% +$757K 0.01% 1479
2014
Q3
$38.3M Sell
678,010
-114,311
-14% -$6.14M 0.01% 1281
2014
Q2
$42.1M Sell
792,321
-453,401
-36% -$24.1M 0.01% 1230
2014
Q1
$65.1M Sell
1,245,722
-1,365,024
-52% -$69.1M 0.02% 870
2013
Q4
$140M Sell
2,610,746
-44,560
-2% -$2.3M 0.05% 473
2013
Q3
$134M Sell
2,655,306
-186,423
-7% -$9.49M 0.05% 448
2013
Q2
$146M Buy
+2,841,729
New +$151M 0.06% 388

Other funds holding SNY

Goldman Sachs's SNY Position: Q1 2026 in Review

Goldman Sachs increased its Sanofi (SNY) stake by 31% in Q1 2026, buying an estimated $28.2M and bringing the position to 2,582,456 shares worth $124M. The position accounts for 0.01% of the portfolio, ranked #905.

Goldman Sachs first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $211M in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Goldman Sachs held 2,582,456 shares of Sanofi worth $124M as of Q1 2026.
  • Goldman Sachs bought 604,853 Sanofi shares in Q1 2026, an estimated $28.2M.
  • Sanofi made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #905 holding.
  • Goldman Sachs first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Sanofi position peaked at $211M in Q3 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.